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Cyclic ADP-ribose (cADPR), a universal calcium mobilizer from
intracellular stores, was recently demonstrated to stimulate pro-
liferation of various cell types. The role of cADPR in a
specific process of monocyte- and plasma-mediated activation of
T-lymphocytes by lipopolysaccharide (LPS) was addressed using
human mononuclear cells from peripheral blood (PBMCs).
Incubation of PBMCs with 0.1 µg/ml of LPS for 24 h provided
a doubling in the intracellular levels of cADPR as compared with
unstimulated PBMCs. The cADPR increase was abolished either
by prior removal of monocytes or by pre-incubating a whole
PBMC population with a monoclonal antibody against the
monocyte marker CD14. The increased concentrations of intra-
cellular cADPR elicited by LPS stimulation were paralleled by
significant increases in NAD+ levels and in the activities of ecto-
cellular and membrane-bound fractions of ADP-ribosyl cyclase/
cADPR hydrolase activities. A cytosolic ADP-ribosyl cyclase was
also detectable in PBMCs and its activity was comparably en-
hanced by LPS stimulation. This soluble cyclase is distinguished
from the membrane-bound cyclase by both substrate and inhibi-
tor sensitivities. LPS-stimulated PBMCs showed 2–3-fold in-
creases of intracellular calcium ([Ca2+]i), and these changes were
prevented completely by the cADPR antagonist 8-Br-cADPR
and by ryanodine. Both compounds, and the cyclase inhibitor
nicotinamide, significantly inhibited the T-lymphocyte prolif-
eration induced by LPS in PBMCs. These results demonstrate
that cADPR plays a role of second messenger in the adaptive
immune recognition process of LPS-stimulated proliferation of
PBMCs.
Key words: ADP-ribosyl cyclase, cyclic ADP-ribose, cyc-
lic ADP-ribose hydrolase, lipopolysaccharide, nicotinamide–
adenine dinucleotide (NAD+), peripheral blood mononuclear cell.
INTRODUCTION
The NAD+ metabolite cyclic ADP-ribose (cADPR) is a universal
signalling molecule that mobilizes calcium from intracellular
stores and regulates accordingly a number of calcium-related cell
processes in organisms ranging from simple protozoa to humans
[1–3]. cADPR-dependent cell functions in mammals include pro-
liferation, contraction, vasodilation and secretion [1–8]. The
mechanism whereby cADPR enhances cell proliferation is related
to shortening of the S phase of the cell cycle in murine 3T3 fibro-
blasts [9]. Moreover, cADPR has been demonstrated to behave as
a new haemopoietic cytokine since it stimulates the proliferation
of human haemopoietic progenitors both in vitro [10,11] and
in vivo [12]. Finally, cADPR proved to be required for the calcium-
related triggering of activation/proliferation of T-lymphocytes
that follows stimulation of the T-cell receptor–CD3 complex
[13].
A well known, potent inducer of B- and T-lymphocyte pro-
liferation is lipopolysaccharide (LPS), the main component of the
cell wall of Gram-negative bacteria [14,15]. Specifically, while
both murine B- and T-lymphocytes have been documented to be
responsive to LPS [16–18], human T-lymphocytes, but not B-
lymphocytes, proved to exhibit responses to LPS in terms of
enhanced proliferation and cytokine production, and such stimu-
Abbreviations used: BST-1, bone marrow stromal cell antigen 1; [Ca2+]i, intracellular Ca2+ concentration; cADPR, cyclic ADP-ribose; IL, interleukin;
LBP, LPS-binding protein; LPS, lipopolysaccharide; mAb, monoclonal antibody; PBMC, peripheral blood mononuclear cell; PCA, perchloric acid; PKC,
protein kinase C; TCA, trichloroacetic acid; TCR, T-cell receptor; TdR, thymidine; TLR, Toll-like receptor.
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lation appears to be mediated by accessory cells including mono-
cytes and CD34+ haemopoietic stem cells [19].
The intracellular mechanisms underlying monocyte- and stem-
cell-mediated activation of T-lymphocytes by LPS are still little
understood, although direct cell-to-cell interactions (e.g. between
CD28 and B7) and release of soluble cytokines [e.g. interleukin
(IL)-12] are involved as extracellular triggering signals [19].
Specifically, no information is currently available on the intra-
cellular signalling pathways that result in the response of human
T-lymphocytes to LPS. Chien et al. [20] reported an activation
of PKC (protein kinase C) without any elevation of intracellular
calcium concentration ([Ca2+]i) in LPS-stimulated isolated human
peripheral T-lymphocytes. On the other hand, stimulation of
the T-cell receptor (TCR)–CD3 complex by the agonistic anti-
CD3 monoclonal antibody (mAb) OKT3 in human Jurkat T-
lymphocytes induced an enhanced ADP-ribosyl cyclase activity,
which resulted in increases in intracellular cADPR levels and
in [Ca2+]i. In the same study, cADPR proved to have a role in
calcium-dependent proliferation of T-lymphocytes purified from
human blood [13]. The current uncertainties about the intracellular
mechanisms of monocyte-mediated T-cell proliferation triggered
by LPS, which represents a paradigmatic process of innate (adapt-
ive) immunity, prompted us to address the possibility of a role
of cADPR in this activation process. The results obtained in
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the present study demonstrate the occurrence of such a role for
cADPR, which proved to behave as a second messenger in the
cascade of events initiated by LPS-primed monocytes and
eventually leading to enhanced proliferation of T-lymphocytes.
MATERIALS AND METHODS
PBMC (peripheral blood mononuclear cell) isolation
and culture conditions
Buffy coats, prepared from blood of healthy volunteer human
donors and obtained from the Red Cross, St. Paul, MN, U.S.A.
and from Galliera Hospital, Genova, Italy, were diluted with equal
volumes of PBS or RPMI 1640 medium. PBMCs were isolated
by density centrifugation over Ficoll-Paque Plus (Amersham Bio-
sciences AB, Uppsala, Sweden), and contaminating erythrocytes
were lysed by resuspending cells for 5 min in the lysing buffer
(0.3 M NH4Cl and 20 mM KHCO3). PBMCs were then resus-
pended with the recovered autologous plasma (upper layer of
the centrifugation gradient), supplemented with 100 units/ml
penicillin and 0.1 mg/ml streptomycin. In the experiments
designed to establish the role of autologous plasma, PBMCs were
alternatively resuspended in RPMI 1640 medium, supplemented
with 10 % foetal calf serum, 100 units/ml penicillin and 0.1 mg/
ml streptomycin. The almost complete absence of granulocytes
(< 3 %) in the isolated PBMCs was verified by May-Grunwald–
Giemsa staining.
PBMCs were cultured at a concentration of 3 × 106 cells/ml
and were either unstimulated or stimulated for various times (1–
48 h) with LPS (serotype 0111:B4 or serotype 055:B5; Sigma) at
concentrations ranging from 0.001 to 10 µg/ml. In experiments
aimed at investigating the monocyte-dependent cADPR increases,
PBMCs were cultured for 2 h in plastic flasks, before LPS
stimulation, and then non-adherent (i.e. monocyte-depleted) cells
were recovered by gentle pipetting. Adherent cells (mainly
represented by monocytes [21,22]) were either discarded or
LPS-primed to explore their effect on cADPR increases. For
CD14-dependent regulation, PBMCs were first cultured with an
anti-CD14 blocking mAb (10 µg/ml biG10, IgG1; Biometec,
Greifswald, Germany) for 1 h. The anti-CD14 mAb was present
in the medium throughout the entire incubation period. An
isotype-matched mAb (anti-Cx26; catalogue no. 13-1800, Zymed
Laboratories, San Francisco, CA, U.S.A.) was used in these
experiments as a negative control.
Determination of intracellular cADPR and NAD+ concentrations
PBMCs were cultured as described above for various times (1, 2,
9, 24 and 48 h). At each time point, 9.0 ml of non-adherent cells
were withdrawn in triplicate and were centrifuged for 10 min at
1000 g. Cell pellets were lysed in 0.5 ml of 0.6 M perchloric acid
(PCA) at 4 ◦C, cADPR and NAD+ contents were determined by
the cycling assay as described [23], and their levels were expressed
as pmol/106 cells and nmol/106 respectively. Briefly, PCA was
removed by mixing the aqueous sample with 4 vol. of a solution
containing 1,1,2-trichlorotrifluoroethane and tri-n-octylamine.
After 1 min of vortex mixing, samples were centrifuged for
10 min at 1500 g, and the aqueous layer, containing cADPR, was
recovered. Samples were then subjected to an overnight treatment
at 37 ◦C with a mixture of enzymes (nucleotide pyrophosphatase,
alkaline phosphatase and NAD+-glycohydrolase), to remove all
contaminating nucleotides. Enzymes were removed by filtration
with a multiscreen vacuum manifold using Immobilon-P mem-
brane plates (Millipore, Bedford, MA, U.S.A.), and reactions for
cADPR determination were then carried out in 96-well plates. A
reagent (50 µl) containing 30 mM nicotinamide, 100 mM sodium
phosphate and 0.1 µg/ml ADP-ribosyl cyclase (Sigma, St. Louis,
MO, U.S.A.) was added to 0.1 ml of sample. In parallel, the
same reagent without ADP-ribosyl cyclase was added to each
sample. Finally, 0.1 ml of the cycling reagent [2 % (v/v) ethanol,
100 µg/ml alcohol dehydrogenase, 20 µM resazurin, 5 µg/ml
diaphorase, 10 µM FMN, 10 mM nicotinamide and 100 mM
sodium phosphate, pH 8.0] were added to each well. The increase
in resorufin fluorescence (544 nm excitation, 590 nm emission)
was measured every 3 min over a 12 h period, using a fluorescence
plate reader (Fluostar Optima, BMG Labtechnologies GmbH,
Offenburg, Germany). To determine endogenous levels of NAD+,
the acidic cell extracts were diluted 200-fold in 100 mM sodium
phosphate buffer, pH 8.0. The cycling reagent (0.1 ml) was added
to 0.1 ml of each sample. Increases in resorufin fluorescence were
acquired every 1 min, as described above. A cADPR or NAD+
standard curve was always run in parallel in each assay.
Assay of ADP-ribosyl cyclase, GDP-ribosyl cyclase and
cADPR-hydrolase activities in monocyte-depleted PBMCs
PBMCs (3 × 106 cells/ml) were either unstimulated or stimulated
with 0.1 µg/ml LPS for 24 or 48 h. Non-adherent PBMCs
(7.0 ml) were then recovered, washed twice with 10 ml of PBS
and resuspended in 3.0 ml of PBS containing 10 mM glucose and
protease inhibitors [0.1 mM aprotinin, 0.1 mM leupeptin, 10 µM
pepstatin, 1 mM 4-(2-aminoethyl)benzenesulphonyl fluoride hy-
drochloride and 1 mM PMSF] (PBS–glu). A 0.5 ml aliquot of cell
suspension was used to measure enzymic activities on intact
cells, whereas the other part (2.5 ml) was lysed by sonication in ice
for 1 min at 3 W (Heat-System Ultrasonics, W-380, New York,
NY, U.S.A.). A 0.5 ml aliquot was used for assay of enzymic ac-
tivities in the total cell lysate. The remaining part was centrifuged
at 1000 g for 5 min, to discard cell debris, and the supernatant
was centrifuged further at 100 000 g for 2 h at 4 ◦C. The resulting
supernatant (S100) was collected and the pellet (P100) was
resuspended in 0.5 ml PBS–glu.
ADP-ribosyl cyclase activity was measured by adding 0.1 mM
NAD+ (final concentration) to intact cells, total cell lysates, or
to S100 and P100 fractions. After NAD+ supply, 100 µl aliquots
were withdrawn at various times (0, 5, 10 and 20 min). Enzymic
reactions were stopped by the addition of 220 µl of 0.9 M PCA
to each aliquot, and cADPR and NAD+ concentrations were
measured by the cycling assay [23].
GDP-ribosyl cyclase activity was determined by adding
0.4 mM NGD+ to intact cells, total cell lysates, or to S100 and
P100 fractions. At various times (0, 15, 60 and 120 min),
100 µl aliquots were withdrawn and trichloroacetic acid (TCA)-
deproteinized. cADPR-hydrolase activity was measured by
incubating total cell lysates with 0.2 mM cADPR for 0, 60 and
180 min. Aliquots were withdrawn at each time point and were
TCA-deproteinized. HPLC analyses of nucleotides (to measure
the production of cGDPR and ADPR respectively) were per-
formed as described [24].
Aliquots collected from incubations with intact cells to measure
ectocellular enzyme activities were first centrifuged at 1000 g
for 5 min at 4 ◦C to remove cells and either PCA or TCA was
added to the supernatant, as described above. All incubations were
carried out at 37 ◦C and protein determination in each sample was
performed according to the method of Bradford [25].
Fluorimetric determination of [Ca2+]i
PBMCs (3 × 106 cells/ml) were pre-incubated in duplicate in the
presence of 50 µM 8-Br-cADPR or 50 µM ryanodine, or without
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any addition. After 1 h, cells were either unstimulated or were
stimulated with 0.1 µg/ml LPS and incubated for 24 or 48 h. Non-
adherent PBMCs (2.0 ml) were then recovered, incubated with
5 µM Fura 2 acetoxymethyl ester for 40 min at 37 ◦C, washed
with a calcium-free solution (135 mM NaCl, 5.4 mM KCl,
1 mM MgCl2 and 5 mM Hepes, pH 7.4) and resuspended in the
same solution at 1.5 × 106 cells/ml. Calcium measurements were
performed at 37 ◦C in a 2 ml cuvette, under continuous stirring.
[Ca2+]i was calculated as previously described [9].
Incorporation of [3H]TdR ([3H]thymidine)
After 1 h of pre-incubation in the presence of 50 µM 8-Br-
cADPR, 20 mM nicotinamide or 50 µM ryanodine, or without
any addition (control), PBMCs were stimulated with 0.1 µg/ml
LPS and were cultured for 72 h. This proved to be the optimum
time, among several times investigated in parallel experiments, to
record significant effects of the different molecules used. 8-Br-
cADPR (50 µM), nicotinamide (20 mM) or ryanodine (50 µM)
was present in the medium throughout the entire incubation
period. For the last 8 h of incubation, non-adherent cells were
recovered and were labelled with [3H]TdR (specific activity of
48 Ci/mmol, 0.2 µCi/culture; Amersham Biosciences) and har-
vested on glass fibre filters (Whatman, Maidstone, U.K.) for
measurements of incorporated radioactivity.
RESULTS
Intracellular cADPR concentrations in LPS-stimulated PBMCs
Freshly isolated human PBMCs, cultured as described in the
Materials and methods section, were stimulated for various
time intervals with 0.1 µg/ml LPS (serotype 0111:B4) and the
intracellular cADPR content was then measured in non-adherent
cells. After 1, 2 and 9 h of incubation, no changes of intracellular
cADPR concentrations were detectable (results not shown).
However, as illustrated in Figure 1(A), after 24 h of stimulation
with LPS, the cADPR content of control cells (0.049 +−
0.010 pmol/106 cells; n = 20) was significantly enhanced (188 +−
21 % of control value; n = 9; P < 0.0001). The increase was no
longer observed when LPS-stimulated PBMCs were resuspended
in RPMI 1640 medium, in the absence of autologous plasma
(Figure 1A). Occasionally (in two out of 11 experiments), we
found a much greater enhancement of cADPR concentration,
accounting for approx. 7-fold increases over the control value.
Comparably high intracellular levels of the cyclic nucleotide were
still present at 48 h of incubation (Figure 1A). When autologous
plasma was diluted 1:1 with PBS or with RPMI 1640 medium,
identical results were obtained.
cADPR is synthesized from NAD+ by ADP-ribosyl cyclase
activities (see below). Thus we also measured the intracellular
NAD+ concentration in PBMCs stimulated with LPS under the
same conditions reported in the legend to Figure 1. PBMCs
were resuspended in the presence of autologous plasma and were
treated for 24 or 48 h with LPS. Non-adherent PBMCs were col-
lected and the NAD+ content was determined: the intracellular
NAD+ concentration of control cells (0.066 +− 0.021 nmol/106
cells; n = 11) was significantly increased in LPS-stimulated cells
(212 +− 45%, n = 7, and 253 +− 70%, n = 4, of control values at
24 and 48 h respectively).
Our PBMC preparations proved to contain less than 3%
granulocytes. Nevertheless, in an attempt to exclude that the
cADPR increase could in fact occur only in a small contaminating
fraction of granulocytes, we isolated (with a Ficoll-Paque Plus
Figure 1 Intracellular cADPR increases in LPS-stimulated PBMCs
PBMCs were isolated and cultured at 3 × 106 cells/ml as described in the Materials and methods
section. (A) After 24 or 48 h of incubation in the absence (white bars) or in the presence of
0.1 µg/ml LPS (black bars), non-adherent PBMCs were collected. Results are means +− S.D.
of nine experiments on nine different donors. Each measurement was performed in triplicate.
(B) Cells were stimulated for 24 h with LPS at the concentrations indicated and non-adherent
PBMCs were collected. Intracellular cADPR content in the recovered PBMCs was determined by
the cycling assay procedure [23]. Results are expressed as percentage values of cADPR content
in control, non-stimulated, PBMCs (0.045 +− 0.09 pmol/106 cells).
centrifugation method followed by removal of erythrocytes with
the lysing buffer, see the Materials and methods section) and
stimulated them with LPS for 24 h. No increase in cADPR con-
centration was detectable in the granulocyte fraction challenged
with LPS (results not shown).
Next, PBMCs were treated with different amounts of LPS,
in order to explore the concentration-dependence of the cADPR
increases. However, as shown in Figure 1(B), an LPS concen-
tration as low as 1 ng/ml was sufficient to trigger a significant
(P < 0.01) increase of intracellular cADPR. Such increases were
found to level off from 0.1 to 10 µg/ml (Figure 1B). Similarly,
intracellular NAD+ content was affected by low concentrations
of LPS (1 ng/ml), and the same extent of increase was observed
for concentrations from 0.1 to 10 µg/ml. Comparable results for
both cADPR and NAD+ contents were obtained using a different
LPS serotype (055:B5).
Role of monocytes and CD14 in LPS-induced increase
of intracellular cADPR
Since the LPS-dependent cellular response of PBMCs is known
to be regulated by the expression of CD14 in monocytes [26–31],
a number of experiments were designed to investigate the role of
these cells on the cADPR increases elicited by LPS stimulation.
First, after removing adherent PBMCs (a common way to remove
monocytes, as routinely tested in our experiments [21,22]), we
recovered and stimulated the non-adherent cells with LPS for
24 h. Under these conditions, the cADPR increase was markedly
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Figure 2 Effect of monocyte depletion and of anti-CD14 antibody on the
LPS-induced cADPR increases in PBMCs
PBMCs were isolated, cultured at 3 × 106 cells/ml in the presence of autologous plasma and
incubated for 1 h in the absence (control) or presence of 10 µg/ml anti-CD14 mAb. In the
last experiments, an isotype-matched mAb was used in the same conditions, yielding results
superimposable on those of the controls (results not shown). PBMCs were then stimulated with
0.1 µg/ml LPS for 24 h. In parallel, isolated PBMCs were cultured for 2 h in plastic flasks
and then non-adherent PBMCs were carefully recovered and stimulated with 0.1 µg/ml LPS for
24 h. Intracellular cADPR content was determined by the cycling assay [23] on non-adherent
PBMCs at the end of incubation: white bars, unstimulated cells; black bars, LPS-stimulated
cells. Results are means +− S.D. of four experiments on four different donors. Each measurement
was performed in triplicate.
restrained as compared with that recorded in the presence of
monocytes (Figure 2). The small increase of cADPR content
in LPS-stimulated non-adherent PBMC over the corresponding
unstimulated control PBMCs was not statistically significant
(P = 0.26). On the contrary, the cADPR content of LPS-stimulated
non-adherent PBMCs was significantly higher (P < 0.05) when
stimulation was performed on the complete PBMC population
(control conditions) than was observed in equally LPS-primed,
monocyte-depleted PBMCs (Figure 2).
In another set of experiments, we evaluated the cADPR con-
centrations in PBMCs after LPS stimulation in the presence of a
specific mAb directed against the monocyte marker CD14 [31].
Co-incubation with the neutralizing anti-CD14 mAb, but not with
an isotype-matched mAb (see the Materials and methods section)
inhibited the LPS-induced cADPR increases in non-adherent
PBMCs almost completely (Figure 2).
Next, the intracellular cADPR concentrations were measured in
non-adherent PBMCs co-incubated with separately LPS-primed
monocytes. Adherent PBMCs were first incubated for various
times (0.5, 1 and 4 h) with LPS. Then, unbound LPS was removed
by washing the adherent cells, and non-adherent cells were
replaced and co-incubated for a further 24 h. As a positive control
for the stimulatory effect of primed monocytes, cADPR levels
were also measured in unfractionated PBMCs, following their
incubation with LPS for 24 h. As shown in Figure 3(A), LPS
priming of the monocyte fraction for 30 min elicited the same
extent of cADPR increase in the PBMCs as in the complete
mixture. Since a 9 h incubation of unfractionated PBMCs with
LPS did not result in any increase in cADPR levels in non-adherent
cells (see above), but 30 min of monocyte priming was sufficient
to enhance intracellular cADPR in the co-incubated non-adherent
cells, it is possible that the briefly primed monocytes need to
interact for as long as 24 h with the non-adherent cells to cause
a cADPR increase therein. Thus we investigated the time-course
of cADPR levels in non-adherent cells following their co-
incubation with monocytes stimulated identically for 30 min with
LPS. As illustrated in Figure 3(B), cADPR content of non-
adherent cells was found to be unchanged after 1 and 9 h of co-
Figure 3 Relationship between LPS priming of isolated monocytes and
cADPR increases in non-adherent PBMCs
Isolated PBMCs were cultured (3 × 106 cells/ml) for 2 h in plastic flasks. (A) Adherent cells
were incubated for 0.5, 1 and 4 h with (black bars) or without (white bars) 0.1 µg/ml LPS.
Unbound LPS was washed out, non-adherent cells were added to the adherent cells and were
co-incubated for a further 24 h. Unfractionated cells were cultured in parallel and stimulated
with LPS for 24 h as described in the Materials and methods section. Intracellular cADPR levels
were determined by the cycling assay [23] in non-adherent PBMCs at the end of incubation.
(B) Adherent cells were incubated for 30 min in the absence (control) or presence of 0.1 µg/ml
LPS. Unbound LPS was removed by washing, and non-adherent cells were replaced and co-
incubated for 1, 9 and 24 h. At the end of each time point, non-adherent cells were recovered
and their intracellular cADPR content was determined by the cycling assay [23]. , control;
, incubated with LPS-primed monocytes. Results are means +− S.D. (n = 3).
incubation with LPS-primed monocytes, whereas it was signi-
ficantly increased at 24 h and kept comparably high after 48 h.
ADP-ribosyl cyclase, GDP-ribosyl cyclase and cADPR-hydrolase
activities in LPS-stimulated PBMCs
In several cell types, cADPR is synthesized from NAD+ by a num-
ber of ADP-ribosyl cyclases, some of which [e.g. those associ-
ated with CD38 and BST-1 (bone marrow stromal cell antigen
1)] feature also cADPR hydrolase activity [3,32]. Thus we
investigated whether or not the increases of intracellular cADPR
could be due to a higher level of ADP-ribosyl cyclase activity
in LPS-stimulated PMBCs than in unstimulated PBMCs. Indeed,
the ADP-ribosyl cyclase activity, measured upon adding NAD+
as a substrate to total lysates from non-adherent PBMCs, was
almost 2-fold higher in the PBMCs incubated with LPS for 24 h,
as compared with unstimulated control cells (Table 1). This LPS-
induced increase of ADP-ribosyl cyclase activity was abolished
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Table 1 Effects of LPS stimulation and of CD14 neutralization on ADP-
ribosyl cyclase and cADPR hydrolase activities of PBMCs
ADP-ribosyl cyclase and cADPR hydrolase activities were determined on total cell lysates, as
described in the Materials and methods section. Results are means +− S.D. (n = 3).
ADP-ribosyl cyclase cADPR hydrolase
PBMCs (pmol of cADPR/min per mg) (nmol of ADPR/min per mg)
Unstimulated 38.21 +− 1.37 0.540 +− 0.070
LPS-stimulated 71.07 +− 5.03 (P < 0.001) 0.964 +− 0.205+ anti-CD14 mAb 38.94 +− 1.40 0.562 +− 0.053+ anti-CD14 mAb + LPS 40.80 +− 2.89 0.621 +− 0.081+ non-specific mAb 41.44 +− 3.15 0.561 +− 0.055+ non-specific mAb + LPS 67.43 +− 6.09 (P < 0.01) 0.915 +− 0.111
by co-incubation of PBMCs with the blocking anti-CD14 anti-
body (Table 1), in agreement with data shown in Figure 2. Bi-
functionality of CD38 and BST-1 prompted us to measure cADPR
hydrolase activity in lysates from control and LPS-stimulated cells
as well. The cADPR-degrading activity of lysates from LPS-
treated PBMCs was enhanced up to approx. 180% of control
values, in accordance with the corresponding increase of the
cyclase activity, and the increase was likewise blocked by the anti-
CD14 mAb (Table 1). A non-specific mAb, used as negative
control (see the Materials and methods section), did not affect
the cyclase and the hydrolase activities of control cells and did
not inhibit the LPS-induced increase of both enzymic activities
(Table 1).
In addition to membrane-bound ADP-ribosyl cyclases (CD38
and BST-1), a soluble cyclase, featuring activity on NAD+, but
not on the substrate analogue NGD+, has been reported in Jurkat
cells [13]. This suggested a comparative investigation of the
substrate specificity of ADP-ribosyl cyclase(s) in intact cells
(i.e. the ectocellular activity related to CD38 and BST-1), in
the cytosol (S100) and in the total membrane fraction (P100)
from both unstimulated (control) and LPS-stimulated PBMCs.
As shown in Table 2, the membrane-bound ADP-ribosyl cyclase
activity was enhanced in LPS-stimulated cells compared with
unstimulated cells. This was demonstrated by assays on intact
cells (from 29.55 +− 4.42 to 48.30 +− 9.66 pmol of cADPR/min per
mg of protein) and on the isolated membrane fraction as well
(from 265.59 +− 48.18 to 395.68 +− 46.92 pmol of cADPR/min
per mg of protein). Moreover, we were able to detect and
measure an ADP-ribosyl cyclase activity also in the cytosolic
fraction (10.51 +− 1.37 pmol of cADPR/min per mg of protein)
that increased upon LPS stimulation (up to 15.32 +− 1.73 pmol of
cADPR/min per mg of protein; P < 0.001). This LPS-dependent
enhancement of cytosolic ADP-ribosyl cyclase activity was
Table 2 Substrate specificity and activity levels of cyclases in various cell compartments
ADP-ribosyl and GDP-ribosyl cyclase activities were determined on intact cells, on total cell lysates and on membrane (P100) and cytosolic (S100) fractions as described in the Materials and
methods section. Results are means +− S.D. (n = 7).
ADP-ribosyl cyclase (pmol of cADPR/min per mg) GDP-ribosyl cyclase (nmol of cGDPR/min per mg)
Cells or cell fractions Unstimulated LPS-stimulated Unstimulated LPS-stimulated
Intact cells 29.55 +− 4.42 48.30 +− 9.66* 1.01 +− 0.11 1.88 +− 0.15†
Total cell lysate 42.86 +− 9.02 72.86 +− 13.93* 1.10 +− 0.24 1.89 +− 0.31*
Membranes 265.59 +− 48.18 395.68 +− 46.92* 3.41 +− 0.52 6.04 +− 1.18*
Cytosol 10.51 +− 1.37 15.32 +− 1.73† ND‡ ND‡
* P < 0.01.
† P < 0.001.
‡ ND, not detectable.
completely prevented by co-incubating the total PBMCs with
the blocking anti-CD14 mAb, but not with the isotype-matched
non-specific mAb (results not shown), as previously observed in
total cell lysates (Table 1). The cytosolic cyclase did not recognize
NGD+ as a substrate (Table 2). Interestingly, GDP-ribosyl cyclase
activity, measured on intact cells, on total cell lysates, and on
membrane fractions as well, was remarkably enhanced in PBMCs
following LPS stimulation (Table 2), in agreement with cor-
responding variations of ADP-ribosyl cyclase activity. The failure
to detect a cytosolic GDP-ribosyl cyclase activity (see above) rules
out any possible membrane contamination as being responsible
for the cytosolic ADP-ribosyl cyclase, which therefore proves
to be an endogenous and specific enzyme activity, as reported
for Jurkat cells [13]. Moreover, absence of measurable cGDPR
production from NGD+ in the cytosolic fraction is not due to a
limited sensitivity of our HPLC analyses: indeed, if cGDPR were
produced at the same level as cADPR in the cytosolic fraction in
comparison with the membrane fraction, cGDPR would be easily
detectable. Since the cytosolic ADP-ribosyl cyclase is devoid
of any activity on NGD+, we investigated whether this dinu-
cleotide has any effect on the cytosolic cyclase activity on NAD+.
Thus we performed experiments of NAD+ saturation in the pres-
ence of NGD+ on both membrane and cytosolic fractions. Rather
surprisingly, NGD+ also inhibited the cytosolic ADP-ribosyl
cyclase, but according to a different mechanism. As shown in
Figure 4, NGD+ behaved as a competitive inhibitor of the
membrane-bound cyclase (K i = 5.4 +− 0.4 µM) and as a non-
competitive inhibitor of the cytosolic activity (K i = 2.0 +−
0.3 µM).
High levels of ADP-ribosyl and GDP-ribosyl cyclase activities,
comparable in extent with those found after 24 h of treatment with
LPS, were still maintained at 48 h of incubation with LPS (results
not shown), in agreement with the correspondingly delayed
persistence of high levels of intracellular cADPR (Figure 1A).
Increased [Ca2+]i in LPS-stimulated PBMCs
The LPS-induced increases of intracellular cADPR concentration
in non-adherent PBMCs prompted us to analyse [Ca2+]i in the
same experimental conditions. As shown in Table 3, stimulation
of PBMCs with LPS resulted in mean [Ca2+]i increases from
32 +− 3 to 72 +− 5 nM (24 h), and from 28 +− 4 to 60 +− 7 (48 h).
These [Ca2+]i in control cells are comparable with those measured
previously in similar cell preparations (cord blood-derived
mononuclear cells [10,11]). In an earlier and independent study
[33], a slightly lower [Ca2+]i increase had been reported to occur
in LPS-stimulated (12 h) PBMCs.
That the enhanced [Ca2+]i following stimulation with LPS was
due to Ca2+ release from intracellular stores was demonstrated
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Figure 4 Distinctive mechanisms of inhibition of membrane-bound and
cytosolic ADP-ribosyl cyclase activities by NGD+
NAD+ saturation curves were generated with membrane-bound cyclase activity (P100; see
the Materials and methods section) (A) and with cytosolic cyclase activity (S100) (B), in the
presence () or absence () of 10 µM NGD+. Results are means +− S.D. (n = 3).
Table 3 Effects of 8-Br-cADPR and of ryanodine on [Ca2+]i of LPS-
stimulated PBMCs
[Ca2+]i was determined as described in the Materials and methods section. Results are
means +− S.D. (n = 3).
[Ca2+]i (nM)
PBMCs incubated for . . . 24 h 48 h
Unstimulated 32 +− 3 28 +− 4
LPS-stimulated 72 +− 5 (P < 0.01) 60 +− 7+ 8-Br-cADPR 25 +− 3 24 +− 4+ 8-Br-cADPR + LPS 26 +− 3 29 +− 4+ ryanodine 14 +− 3 12 +− 2+ ryanodine + LPS 22 +− 4 25 +− 3
by experiments with thapsigargin (Figure 5). Thus the LPS-
stimulated PBMCs showed diminished increases in [Ca2+]i
induced by 10 µM thapsigargin, in comparison with the unsti-
mulated cells.
In an attempt to correlate the changes in [Ca2+]i with the
increased concentrations of intracellular cADPR, we incubated
cells in the presence or absence of 50 µM 8-Br-cADPR, a well-
known cADPR antagonist [34], and in the presence or absence of
50 µM ryanodine, a concentration that shows inhibitory effects
on cADPR-sensitive calcium stores [3]. Both 8-Br-cADPR and
Figure 5 Thapsigargin-releasable Ca2+ in LPS-stimulated PBMCs
PBMCs were isolated and cultured at 3 × 106 cells/ml in the presence of autologous plasma,
with or without 0.1 µg/ml LPS. After 24 h, cells were loaded with Fura 2 acetoxymethyl ester.
Control and LPS-stimulated cells were challenged with 10 µM thapsigargin in a calcium-free
solution (see the Materials and methods section) as indicated by the first arrow. The second arrow
indicates the addition of 5 µM ionophore (A23187) and 5 mM EGTA. Traces are representative
of three different experiments.
ryanodine completely prevented the LPS-induced [Ca2+]i increase
(Table 3), indicating a causal role of cADPR in up-regulating
[Ca2+]i following stimulation of PBMCs with LPS.
Role of cADPR in LPS-induced PBMC proliferation
Stimulation of PBMCs with LPS has been reported to result in
cell proliferation. Only T-lymphocytes were reported to represent
the proliferating cell population after stimulation with LPS,
whereas B-lymphocytes, natural killer (NK) cells and monocytes
were unresponsive to LPS stimulation [19,35]. Moreover, a role
for cADPR in the proliferation of T-cells has been demon-
strated following stimulation of the TCR–CD3 complex [13].
Therefore, in an attempt to correlate PBMC proliferation with
the recorded increases in cADPR concentrations and in [Ca2+]i
that follow priming with LPS, we performed experiments of
[3H]TdR incorporation in the presence or absence of 8-Br-
cADPR, in the presence and absence of nicotinamide, an inhibitor
of the membrane-bound ADP- and GDP-ribosyl cyclase activities
[36], and in the presence and absence of ryanodine. Before
these experiments, the effect of nicotinamide on the cytosolic
ADP-ribosyl cyclase activity was also investigated: with 10 mM
nicotinamide, the soluble ADP-ribosyl cyclase activity was
inhibited by 90% (from 10.06 +− 0.99 to 0.89 +− 0.21 pmol of
cADPR/min per mg of protein). After 72 h of incubation with LPS,
[3H]TdR incorporation was decreased to approx. 30% by 50 µM
8-Br-cADPR as compared with the control (Table 4). Incubation
in the presence of either 20 mM nicotinamide or 50 µM ryanodine
completely prevented the effect of LPS on [3H]TdR incorporation
(Table 4).
DISCUSSION
LPS released from Gram-negative bacteria is responsible for
many adverse reactions including fever, hypotension, tachypnoea,
agranulocytaemia, disseminated intravascular coagulation and
failure of several parenchymatous organs [37]. The heterogeneity
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Table 4 Effects of 8-Br-cADPR, nicotinamide and ryanodine on LPS-
induced proliferation of PBMCs
Proliferation of PBMCs was determined by means of [3H]TdR incorporation as described in the
Materials and methods section. Results, expressed as c.p.m., are means +− S.D. (n = 4).
PBMCs Incorporation of [3H]TdR (72 h)
Unstimulated 1288 +− 100
LPS-stimulated 2146 +− 132 (P < 0.005)+ 8-Br-cADPR 1200 +− 100+ 8-Br-cADPR + LPS 1500 +− 191+ nicotinamide 1266 +− 91+ nicotinamide + LPS 1207 +− 29+ ryanodine 1390 +− 62+ ryanodine + LPS 1236 +− 174
of these effects stems from the many cell types that are responsive
to LPS either directly or indirectly. In the latter case, multiple
autocrine and paracrine loops have been identified where distinct
cytokines and contact mechanisms contribute to a wide range
of effects [19,30,31,38–42]. Dissecting the mechanisms that
ultimately result in many pathophysiological reactions to LPS
is a major goal of molecular studies on infectious diseases.
More recently, a new complex process has been reported
whereby LPS is able to induce human T-lymphocyte proliferation
and cytokine production [19]. LPS is non-mitogenic on purified
human T-cells nor is it competent to affect [Ca2+]i in these
cells [20]. This specific activation of T-lymphocytes is in fact
mediated by accessory cells including monocytes and CD34+
haematopoietic stem cells [19]. In the case of monocyte–
lymphocyte interactions, LPS triggers both direct cell-to-cell
contact, e.g. CD28/B7 binding, and release of soluble cytokines,
e.g. IL-12 [27]. Several lines of evidence indicate that this major
histocompatibility complex (MHC)-unrestricted activation of T-
lymphocytes, which qualifies as an antimicrobial innate immune
response [43], occurs via mechanisms other than those elicited by
mitogens, superantigens and antigens.
The findings of enhanced calcium-mediated cell proliferation
afforded by cADPR in different cell types [9–11], including T-
lymphocytes [13], suggested an investigation of whether or not
this cyclic nucleotide is involved in the monocyte-mediated
activation of T-lymphocytes by LPS. This proved to be the case
because human PBMC preparations were found to respond to LPS
concentrations as low as 1 ng/ml, with significant increases in
intracellular cADPR taking place after 24 h. These increases were
paralleled by two changes in the same direction that are closely
related to cADPR metabolism: (i) remarkably higher intracellular
concentrations of NAD+, suggesting regulation of cADPR syn-
thesis at the substrate level, as previously shown in different
cell systems [44]; and (ii) significantly higher levels of ADP-
ribosyl cyclase activity, consistent with its involvement in up-
regulating intracellular cADPR generation (see below). Thus
enhanced cADPR synthesis as a consequence of LPS stimulation
of monocytes probably reflects corresponding variations of both
ADP-ribosyl cyclase activity and its substrate.
The increases of intracellular cADPR in PBMCs following their
stimulation with LPS proved to be responsible for the observed
up-regulation of [Ca2+]i that occurs in this condition (Table 3).
This was also indicated by the remarkably diminished size of
thapsigargin-sensitive calcium stores that characterizes the LPS-
stimulated PBMCs as compared with the unstimulated control
cells (Figure 5). Persistence of these cADPR-mediated increases
in [Ca2+]i over many hours is in agreement with the earlier
observation that de novo appearance of intracellular cADPR in
CD38-transfected 3T3 fibroblasts and HeLa cells resulted in
the stable doubling of [Ca2+]i [9]. Moreover, the increase of
intracellular cADPR in cord blood-derived mononuclear cells,
either obtained by pre-loading with extracellular cADPR or by
co-culture over cADPR-generating stromal cell lines, resulted
in long-lasting increases in [Ca2+]i [10,11]. Therefore, a causal
correlation between the up-regulation of ADP-ribosyl cyclase,
increased intracellular cADPR concentrations and enhanced
[Ca2+]i, all changes occurring on a time-scale of hours/days, is
a well-documented finding that received further confirmation in
the present study.
The effects of LPS priming of monocytes on metabolism of
cADPR in PBMCs require the presence of autologous plasma.
Interestingly, LPS-binding proteins (LBPs) present in plasma
have been shown to favour the interaction of LPS with the
monocyte marker CD14 and LBPs proved to be necessary at
LPS concentrations below 0.1 µg/ml [45]. Also, since most of the
effects reported in the present study require culturing PBMCs for
at least a short period of time, serum is necessary to preserve cell
viability [46].
The cADPR increases in LPS-stimulated non-adherent PBMCs
were monocyte- and CD14-dependent (Figure 2), as previously
reported for the activation of T-lymphocytes by LPS [26–31].
Another characteristic feature of this system was that a 30 min
priming of monocytes with LPS was sufficient to elicit the
observed increases in cADPR concentration. Mattern et al. [35,47]
reported that LPS stimulation of PBMCs was highly donor-
dependent: only 50% of the healthy donors they tested being
responsive in terms of T-cell proliferation. This was not the
case for the LPS-induced increases in intracellular cADPR in
PBMCs, which were actually recorded in all of our experiments.
Accordingly, the variability observed by Mattern et al. [35,47]
seems to be due to some step(s) downstream of cADPR generation
occurring in the effector T-lymphocytes as a consequence of their
interaction with the LPS-primed monocytes.
It is worth noting that LPS binding and its consequent signalling
effects are exceedingly complex [43]. Evidence has emerged
that the glycosylphosphoinositide-anchored protein CD14 must
interact with the transmembrane receptors triggering signal
transduction, e.g. integrins CD11c, Toll-like receptors (TLRs,
and especially TLR4), CD55 [43,48]. A comparable extent of
complexity characterizes the intracellular interactions of the
cytoplasmic domain of the TLRs with proteins including MyD88,
IL-1 receptor-associated kinase family members and Toll-
interacting protein, with the resulting activation of a unique
signalling module [49]. Subsequently, other signalling pathways
are activated downstream, including NF-κB (nuclear factor κB),
c-Jun N-terminal kinase and p38 MAPKs (mitogen-activated
protein kinases) [43,49].
Whatever the mechanisms, the present results demonstrate that
cADPR in T-lymphocytes has a role of second messenger in the
signalling cascade initiated by the LPS–monocyte interaction,
involving enhanced [Ca2+]i and eventually up-regulating T-cell
proliferation.
The long time interval (24 h) required for the observed effects
to take place is suggestive of some variations in the turnover of
ADP-ribosyl cyclase(s). A clear correlation between ADP-ribosyl
cyclase expression and intracellular cADPR concentration has
already been demonstrated in different cell lines: Zocchi et al. [9]
showed that CD38 transfection in CD38− cells leads to the appear-
ance of intracellular cADPR. Munshi et al. [36] demonstrated an
unequivocal correlation between the extent of CD38 expression
in retinoic-acid-stimulated HL60 cells and intracellular cADPR
levels. Moreover, Guse et al. [13] reported that an enhancement,
upon stimulation of the TCR–CD3 complex, of ADP-ribosyl
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cyclase activity in Jurkat cells is followed by an increased amount
of intracellular cADPR. As far as ADP-ribosyl cyclase activities
in PBMCs are concerned, it is worth noting that, in addition
to membrane-bound cyclase activity, a cytosolic, nicotinamide-
inhibitable ADP-ribosyl cyclase devoid of any activity on the
substrate analogue NGD+ was measurable in non-adherent
PBMCs. This finding confirms the earlier report of a soluble
ADP-ribosyl cyclase in Jurkat cells [13].
Both the membrane-bound and the cytosolic ADP-ribosyl
cyclase activities of non-adherent PBMCs were increased signi-
ficantly following interaction with LPS-stimulated monocytes in
the presence of plasma (Table 2). Therefore both enzyme forms
might in principle be responsible for the observed increases of
intracellular cADPR levels. Recently, the functioning of vesicle-
bound CD38 in generating functionally active, intracellular
cADPR has been challenged and shown to be feedback-inhibited
by high cytosolic [Ca2+]i via a PKC-mediated phosphorylation
of connexin 43 hemichannels [50]. The consequent closure of
these specific hemichannels, which are competent for equi-
librative NAD+ transport [51], restricts the availability of NAD+
to intravesicular CD38, thereby down-regulating subcellular
conversion of NAD+ into cADPR. The cytosolic ADP-ribosyl
cyclase detected in T-lymphocytes, although potentially regulated
via other mechanisms, is certainly not restrained by these com-
partmentalization processes. Accordingly, the soluble enzyme
form is a reasonable candidate for synthesizing higher amounts
of intracellular cADPR as a response to the interaction with LPS-
primed monocytes.
The last step of the signalling cascade initiated by LPS-
stimulated monocytes is T-lymphocyte proliferation. Suscepti-
bility of enhanced PBMC proliferation to inhibition by the
cADPR antagonist 8-Br-cADPR [34], by the cyclase inhibitor
nicotinamide and by ryanodine (Table 4) clearly indicates the role
of second messenger played by cADPR in this cascade of events.
The possibility of 8-Br-cADPR counteracting the effects of LPS
stimulation within monocytes rather than in T-lymphocytes seems
to be quite unlikely. In fact, LPS does not affect CD38 expression
in monocytes [52], nor is any evidence available for an effect of
cADPR in LPS stimulation on monocytes.
Our present findings are in agreement with the previous report
of a causal role of cADPR in the T-cell activation elicited by
the agonistic anti-CD3 antibody, OKT3 [13]. Thus cADPR turns
out to represent a second messenger for calcium-mediated up-
regulation of human T-cell proliferation whose intracellular gen-
eration is activated by more than one agonistic stimulus.
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